Novel approaches to female sexual dysfunction

被引:13
|
作者
Berman, LA [1 ]
Berman, JR [1 ]
Chhabra, S [1 ]
Goldstein, I [1 ]
机构
[1] Boston Univ, Med Ctr, Div Urol, Boston, MA 02215 USA
关键词
apomorphine; female pelvic anatomy; female sexual disorders; female sexual dysfunction; L-arginine; methyltestosterone; neurogenic mediators; oestrogen; phentolamine; prostaglandin E1; sildenafil; testosterone; yohimbine;
D O I
10.1517/13543784.10.1.85
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Female sexual dysfunction is age-related, progressive and highly prevalent, affecting 30 - 50% of American women. While there are emotional and relational elements to sexual function, it has become increasingly evident that female sexual dysfunction can occur secondary to medical problems and has an organic basis. A plethora of different female sexual dysfunctions exist and in order to obtain a greater understanding of the possible treatments for these problems, it is essential to have a strong knowledge base of female pelvic anatomy, the neurogenic mediators of female sexual response, the impact of hormones on female sexual function and the aetiologies of female sexual dysfunction. Currently, there are potential therapeutic options for the treatment of female sexual dysfunction and these options include both hormonal and pharmacological therapy. However, therapeutic agents may not prove to be enough and the ideal approach to female sexual dysfunction is thus a collaborative effort between therapists and physicians, which should include a complete medical and psychosocial evaluation, as well as inclusion of the partner or spouse in the evaluation and treatment process.
引用
收藏
页码:85 / 95
页数:11
相关论文
共 50 条
  • [1] Treatment of female sexual dysfunction
    Ragucci, KR
    Culhane, NS
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (04) : 546 - 555
  • [2] Female sexual satisfaction and pharmaceutical intervention: A critical review of the drug intervention studies in female sexual dysfunction
    Nijland, Esme
    Davis, Susan
    Laan, Ellen
    Schultz, Willibrord Weijmar
    JOURNAL OF SEXUAL MEDICINE, 2006, 3 (05) : 763 - 777
  • [3] Use of sildenafil for female sexual dysfunction
    Shields, Kelly M.
    Hrometz, Sandra L.
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (05) : 931 - 934
  • [4] Testosterone for Treating Female Sexual Dysfunction
    Simon, James A.
    Ohleth, Kathleen
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2025, 68 (01) : 60 - 67
  • [5] Female sexual dysfunction in postmenopausal women
    Castelo-Branco, Camil
    Cancelo, Maria J.
    Chedraui, Peter
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (06) : 639 - 647
  • [6] Female sexual dysfunction
    Korda, J. B.
    UROLOGE, 2008, 47 (01): : 77 - 89
  • [7] Female sexual dysfunction
    Erdogan Aslan
    Michelle Fynes
    International Urogynecology Journal, 2008, 19 : 293 - 305
  • [8] Female sexual dysfunction
    Aslan, Erdogan
    Fynes, Michelle
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2008, 19 (02) : 293 - 305
  • [9] Female sexual dysfunction
    Kershaw, Victoria
    Jha, Swati
    OBSTETRICIAN & GYNAECOLOGIST, 2022, 24 (01) : 12 - 23
  • [10] Female Sexual Dysfunction
    Clayton, Anita H.
    Hamilton, David V.
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2010, 33 (02) : 323 - +